Effect of vitamin D, vitamin D + calcium supplementation on nonalcoholic fatty liver disease
Phase 3
Completed
- Conditions
- onalcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classified
- Registration Number
- IRCT201408312709N29
- Lead Sponsor
- Vice chancellor for research, iran university of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Willingness to participate in this clinical trial, do not consume alcohol, not smoking, age 18 to 65 Years, BMI less than 35 (kilograms by the square of height), not taking certain medications (hepatotoxic drugs such as phenytoin, amiodarone, levothyroxine), not having these diseases (diabetes, heart, liver, kidney, lung), Not having inherited disorders affecting the liver (iron and copper storage disease, etc), not professional athlete, avoiding the use of nutritional supplements in the past 3 months.
Exclusion criteria:
Unwillingness to cooperate, taking nutritional supplements, pregnancy or lactation, smoking, alcohol consumption, intake of less than 70% of prescribed pills.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method